Abstract
Background: Head and neck oncology patients are often dehydrated and less mobile, which in combination with their oncology diagnosis puts them at greater risk of developing thrombotic events. [1] Anti-coagulating patients with low molecular weight heparin however increases their risk of bleeding intra- and post-surgery. Deciding whether to anti-coagulate a patient pre-surgery involves weighing up their risk of bleeding vs their risk of thrombus formation. [2]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Oral and Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
